Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Director | $5.97 M | -$339 K | -5.37% | Jun 14, 2024 |
BRNS, VACC | Barinthus Biotherapeutics plc. | Director | May 10, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|